Courtney E, Chok AK-L, Ting Ang ZL, Shaw T, Li S-T, Yuen J, et al. Impact of free cancer predisposition cascade genetic testing on uptake in Singapore. npj Genom Med. 2019;4:22.
Google Scholar
Roberts MC, Dotson WD, DeVore CS, Bednar EM, Bowen DJ, Ganiats TG, et al. Delivery of cascade screening for hereditary conditions: a scoping review of the literature. Health Aff. 2018;37:801–8.
Google Scholar
George R, Kovak K, Cox SL. Aligning policy to promote cascade genetic screening for prevention and early diagnosis of heritable diseases. J Genet Couns. 2015;24:388–99.
Google Scholar
Frey MK, Ahsan MD, Bergeron H, Lin J, Li X, Fowlkes RK, et al. Cascade testing for hereditary cancer syndromes: should we move toward direct relative contact? A systematic review and meta-analysis. J Clin Oncol. 2022;40:4129–43.
Google Scholar
Forrest LE, Delatycki MB, Curnow L, Skene L, Aitken M. Genetic health professionals and the communication of genetic information in families: practice during and after a genetic consultation. Am J Med Genet Part A. 2010;152A:1458–66.
Google Scholar
Healey E, Taylor N, Greening S, Wakefield CE, Warwick L, Williams R, et al. Quantifying family dissemination and identifying barriers to communication of risk information in Australian BRCA families. Genet Med. 2017;19:1323–31.
Google Scholar
Srinivasan S, Won NY, Dotson WD, Wright ST, Roberts MC. Barriers and facilitators for cascade testing in genetic conditions: a systematic review. Eur J Hum Genet. 2020;28:1631–44.
Google Scholar
Marleen van den Heuvel L, Stemkens D, van Zelst-Stams WAG, Willeboordse F, Christiaans I. How to inform at-risk relatives? Attitudes of 1379 Dutch patients, relatives, and members of the general population. J Genet Couns. 2020;29:786–99.
Google Scholar
Rosén A, Krajc M, Ehrencrona H, Bajalica-Lagercrantz S. Public attitudes challenge clinical practice on genetic risk disclosure in favour of healthcare-provided direct dissemination to relatives. Eur J Hum Genet. 2024;32:6–7.
Google Scholar
Gaff C, Hodgson J. A genetic counseling intervention to facilitate family communication about inherited conditions. J Genet Couns. 2014;23:814–23.
Google Scholar
Hodgson JM, Metcalfe SA, Aitken M, Donath SM, Gaff CL, Winship IM, et al. Improving family communication after a new genetic diagnosis: a randomised controlled trial of a genetic counselling intervention. BMC Med Genet. 2014;15:33.
Google Scholar
Sermijn E, Delesie L, Deschepper E, Pauwels I, Bonduelle M, Teugels E, et al. The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety. Fam Cancer. 2016;15:155–62.
Google Scholar
Evans DGR, Binchy A, Shenton A, Hopwood P, Craufurd D. Comparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relatives. Clin Genet. 2009;75:124–32.
Google Scholar
van El CG, Baccolini V, Piko P, Cornel MC. Stakeholder views on active cascade screening for familial hypercholesterolemia. Healthcare. 2018;6:108.
Aktan-Collan K, Haukkala A, Pylvänäinen K, Järvinen HJ, Aaltonen LA, Peltomäki P, et al. Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing. J Med Genet. 2007;44:732–8.
Google Scholar
Megan CR, David Dotson W, Christopher SD, Erica MB, Deborah JB, Theodore GG, et al. Delivery of cascade screening for hereditary conditions: a scoping review of the literature. Health Aff. 2018;37:801–8.
Google Scholar
Marks D, Thorogood M, Neil SM. Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes. J Med Screen. 2006;13:156–9.
Google Scholar
Henrikson NB, Blasi P, Figueroa Gray M, Tiffany BT, Scrol A, Ralston JD, et al. Patient and family preferences on health system-led direct contact for cascade screening. J Personal Med. 2021;11:538.
Google Scholar
Dheensa S, Lucassen A, Fenwick A. Limitations and pitfalls of using family letters to communicate genetic risk: a qualitative study with patients and healthcare professionals. J Genet Counsel. 2018;27:689–701.
Google Scholar
Öfverholm A, Karlsson P, Rosén A. The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer. Eur J Hum Genet. 2024;32:539–44.
Tiller JM, Stott A, Finlay K, Boughtwood T, Madelli EO, Horton A, et al. Direct notification by health professionals of relatives at-risk of genetic conditions (with patient consent): views of the Australian public. Eur J Hum Genet. 2024;32:98–108.
Google Scholar
Menko FH, van der Velden SL, Griffioen DN, Ait Moha D, Jeanson KN, Hogervorst FBL, et al. Does a proactive procedure lead to a higher uptake of predictive testing in families with a pathogenic BRCA1/BRCA2 variant? A family cancer clinic evaluation. J Genet Couns. 2024;33:615–22.
Google Scholar
van den Heuvel LM, Hoedemaekers YM, Baas AF, Baars MJH, van Tintelen JP, Smets EMA, et al. A tailored approach to informing relatives at risk of inherited cardiac conditions: results of a randomised controlled trial. Eur J Hum Genet. 2022;30:203–10.
Google Scholar
Suthers GK, Armstrong J, McCormack J, Trott D. Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder. J Med Genet. 2006;43:665–70.
Google Scholar
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JGA. metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42:377–81.
Google Scholar
StataCorp. Stata Statistical Software: Release 17. College Station, TX: StataCorp LLC; 2021.
Vears DF, Gillam L. Inductive content analysis: a guide for beginning qualitative researchers. Focus Health Profess Educ A Multi-Profess J. 2022;23:111–27.
Google Scholar
Stott A, Madelli EQ, Boughtwood T, Nowak KJ, Otlowski M, Tiller J. Health professionals contacting patients’ relatives directly about genetic risk (with patient consent): current clinical practice and perspectives. Eur J Hum Genet. 2024; https://doi.org/10.1038/s41431-024-01730-8.
Nääs C, von Salomé J, Rosén A. Patients’ perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare-assisted risk disclosure. Eur J Hum Genet. 2024;32:448–55.
Google Scholar
link
More Stories
Veterinary DNA Testing Market Size
KFSHRC Achieves 39% Rise in
Genomic screening reveals hidden health risks of patients